Stathmin expression in metastatic colorectal cancer

Area of Science:

• Oncology
• Molecular Biology

Background:

• Stathmin is a key phosphoprotein regulating microtubule dynamics and cellular signaling.
• Stathmin plays a role in the tumorigenesis of various cancers, making it a potential therapeutic target.

Purpose of the Study:

• To investigate the association between stathmin expression and clinical outcomes in colorectal cancer (CRC).
• To explore the correlation of stathmin with tumor cell proliferation and apoptosis in metastatic CRC (mCRC).

Main Methods:

• Immunohistochemistry (IHC) was used to assess stathmin expression in 25 mCRC patients.
• Ki67 IHC and TUNEL assays were employed to evaluate cell proliferation and apoptosis in mCRC samples.

Main Results:

• Elevated stathmin expression was linked to CRC metastasis (p=0.0084) and significantly worse overall survival (p=0.036).
• Liver metastases showed increased proliferation and decreased apoptosis compared to primary tumors (p<0.0001).
• A positive correlation was found between stathmin levels and cell proliferation in both primary and metastatic CRC (p=0.0429-0.0451).

Conclusions:

• Stathmin expression is associated with unfavorable prognosis and increased cell proliferation in mCRC patients.
• Stathmin may serve as a prognostic marker for CRC-specific mortality risk.
• Stathmin represents a promising therapeutic target for mCRC treatment.